with complex congenital heart disease (CHD) is important for clinical management but has not been undertaken. We compared matrix-array 3D echocardiography (3D echo) measurements of volumes, mass, and ejection fraction (EF) with those measured by cardiac MRI in young patients with CHD and small LVs because of either young age or LV hypoplasia. Methods and Results-Thirty-five patients aged Ͻ4 years (median, 0.8 years) undergoing MRI were prospectively enrolled. Three-dimensional echo was acquired immediately after MRI, and volume, mass, and EF measurements, using summation of discs methodology, were compared with MRI. Three-dimensional echo end-diastolic volume (24.4Ϯ15.7 versus 24.8Ϯ46.4 mL; Pϭ0.01; intraclass correlation coefficient [ICC], 0.96) and end-systolic volume (12.3Ϯ8.6 versus 9.6Ϯ6.8 mL; PϽ0.001; ICC, 0.90) correlated with MRI with small mean differences (Ϫ0.49 mL [Pϭ0.6] and 2.7 mL [Pϭ0.001], respectively). Three-dimensional echo EF was smaller than MRI by 9.3% (PϽ0.001), and 3D echo LV mass measurements were comparable to MRI (17.3Ϯ10.3 versus 17.6Ϯ12 g; PϽ0.77; ICC, 0.93), with a small mean difference (1. 1 g; Pϭ0.28 ). There was good intra-and interobserver reliability for all measurements. Conclusions-In neonates and infants with CHD and small LVs (age appropriate or hypoplastic), matrix-array 3D echo measurements of mass and volumes compare well with MRI, providing an important modality for ventricular size and performance analysis in these patients, particularly in those with left-side heart obstructive lesions. (Circ Cardiovasc Imaging. 2010;3:735-742.)
D etermination of left ventricular (LV) volumes in small, young patients, especially those with complex congenital heart disease (CHD), is integral to medical and surgical management. 1, 2 LV volumes have and continue to be used as key determinants of suitability for 1-versus 2-ventricular repair. 3, 4 To date, measurements have been based on 2D echocardiography, applying formulas that make inherent assumptions about LV geometry. However, in young pediatric patients with complex CHD, the LV is distorted and does not assume a typical ellipsoid shape, limiting the accuracy of 2D echocardiographic evaluation of mass and volumes. 5, 6 In complex defects, the right ventricle is enlarged and hypertensive, and both directly affect ventricular septal position and LV contour. 7 Moreover, the LV may have an abnormal shape in critically ill newborns with severe valvar aortic stenosis, Shone syndrome, or variants of left-sided heart hypoplasia. Hence, calculation of LV volumes based on geometric assumptions would not be applicable.
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Considerable effort has been undertaken to use various threshold levels of LV volume and mass to decide on the type of surgical intervention. 4, 8 However, even when using risk stratification scores, deciding which ventricles will be able to perform systemic work continues to be problematic. 9 MRI summation of discs has been applied to measure LV volumes in these young patients. 4 However, MRI scans may require general anesthesia, and in some instances mechanical venti-lation, and involve a series of breath holds that may be associated with hemodynamic compromise in some of these very ill infants.
Matrix-array 3D echocardiography (3D echo) can acquire full-volume data sets over 4 cardiac cycles that can subsequently be analyzed by a similar summation of discs methodology. This method potentially obviates the problems of geometric assumptions of LV shape and should be applicable to the newborn infant or young child with complex CHD. 10, 11 Thus, the purpose of this study was to compare 3D echo measurements of LV volumes, mass, and ejection fraction (EF) to measurements obtained simultaneously by MRI in neonates and infants with complex CHD.
Methods
This study consisted of a subset population of neonates and infants with CHD who were aged Յ4 years and had undergone a clinically indicated MRI scan between December 2004 and November 2006 with simultaneous 3D echo obtained as part of a prospective research protocol comparing 3D echo to MRI. All patients were included irrespective of diagnosis if the MRI included LV full-volume data sets. This included 4 patients with LVs that were deemed too small to sustain a cardiac output, thus having undergone varying staged single-ventricle surgeries. (Four of the 35 patients were part of a previously reported prospective protocol that investigated 3D measurement of systemic ventricular volumes in children with functional single ventricles. 10 ) Patients were excluded if the MRI was obtained because of suboptimal echocardiographic acoustic windows resulting in poor image quality. Informed consent was obtained from the children's guardians. The study was approved by the Committee on Clinical Investigation, Children's Hospital Boston, and the Scientific Review Committee, Department of Cardiology.
Matrix-Array 3D Echo

Image Acquisition
Electrocardiography-gated full-volume 3D echo data sets were obtained using a 2-to 4-MHz matrix-array probe and 3D echo system (SONOS 7500; Philips Medical Systems; Andover, Mass) immediately after completion of MRI and during the same anesthesia. Gain and compression were set at 50%. Harmonic imaging was used to optimize signal-to-noise ratio and enhance epicardial and endocardial border visualization. Data sets were acquired from the subcostal position. Mechanical ventilation was suspended and the probe held motionless during the 4-beat acquisition period. The 3D volume data set was then evaluated to ensure that the entire ventricle was optimally scanned with minimal spatial and temporal artifacts. 10 
3D Echo Data Analysis
Analysis of 3D echo data were performed blinded to MRI results. LV volumes, mass, and EF were measured off line by summation of disc methodology with dedicated software (4-D EchoView; TomTec; Munich, Germany). Summation of disc methodology was used as it is used in MRI, thereby allowing direct comparison of the methodologies. The data set was aligned in 2 orthogonal planes along the long axis of the LV with clear depiction of the mitral valve and LV apex. Brightness and contrast were adjusted to optimize signal-tonoise ratio. End diastole was chosen as the largest chamber size and end systole as the smallest chamber size. Atrioventricular valve closure and opening also were used to improve delineation of end diastole and end systole. With use of still and motion frames, endocardial and epicardial borders were manually traced from at least 6 corresponding cross-sectional planes ( Figure 1 ). EF was calculated as (EDVϪESV)/EDV, where EDV is end-diastolic volume and ESV, end-systolic volume. Myocardial mass was calculated as myocardial volume between the epicardial and endocardial bordersϫmyocardial density (1.05 g/mL). LV mass was not calculated when the epicardial border was not adequately seen.
Cardiac MRI Studies
Cardiac MRI studies were performed on a 1.5-T Achieva Intera scanner (Philips Medical Systems; Best; The Netherlands) under general anesthesia with endotracheal intubation. Ventricular dimensions and function were assessed with an electrocardographic-gated steady-state free-precession cine MR sequence (echo time, 1.5 to 1.9 ms; repetition time, 2.6 to 3.9 ms; in-plane resolution, 1.5 to 2.0 mm; slice thickness, 4 to 5 mm; number of retrospectively reconstructed images per cardiac cycle, 30) acquired in the ventricular short-axis plane during brief periods (10 to 40 seconds) of suspended mechanical ventilation, covering the heart from the plane of the atrioventricular valves through the cardiac apex. Ventricular EDV (maximal), ESV (minimal), mass, stroke volumes, and EF were measured with commercially available software (MASS; Medis; Leiden, The Netherlands). 10 With the use of still and motion frames, the endocardial and epicardial borders were manually traced in all ventricular slices. Short-axis images were cross-referenced to long-axis images to help distinguish between atrial and ventricular locations at the ventricular base.
Data Analysis
LV volumes, mass, and % EF by 3D echo and MRI were compared by paired Student t test. Relations between measurements were investigated using linear regression models and intraclass correlation coefficients (ICCs). Bland-Altman limits of agreement were evaluated for each parameter using natural logarithmic transformations for all measures except for EF to account for differences in body size among patients. 12 Similar analysis was performed for the subset of patients with left-sided obstructive lesions and extremely small LVs. Because frame rate and resolution limitations may influence measurement of LV volumes dependent on patient size, we compared the mean difference in LV EDV and ESV measured by MRI and 3D echo between infants with a median body surface area (BSA) Ͻ0.37 m 2 and those a BSA Ն0.37 m 2 . Statistical analysis was performed using SPSS (SPSS Inc; Chicago, Ill). Statistical significance was set at PϽ0.05.
Intraobserver reliability was determined by the same observer at 2 separate sittings Ͼ4 weeks apart in 8 consecutive studies. Interobserver reliability was assessed by 2 separate observers at 2 separate sittings. Inter-and intraobserver reliability was assessed using ICC. The mean bias and SD in natural logarithmic units also are reported.
Results
Forty 3D echo data sets were reviewed. Five were excluded because of incomplete LV volume capture (nϭ4) or inadequate endocardial definition (nϭ1), leaving 35 (87.5%) children eligible for inclusion. Median age was 9.5 months (range, 0.03 to 46.1 months); median weight, 7 kg (range, 2.6 to 18.1 kg), and median BSA, 0.37 m 2 (range, 0.19 to 0.7 m 2 ). The wide spectrum of diagnoses, LV volumes, mass, and EF by 3D echo and MRI are shown for individual patients in Table 1 .
Three-dimensional echo LV EDV (Figure 2 A-D; Table 2 ) and LV mass (Figure 3 A-D; Table 2 ) correlated and agreed with MRI. Three-dimensional echo LV ESVs correlated with MRI but were systematically higher (Figure 4 A-D; Table 2 ). EF by 3D echo correlated with MRI but was lower than MRI by 9.3% ( Figure 5 A-B ; Table 2 ). 
Patients With Left-Sided Obstructive Lesions
Fifteen patients had severe left-sided obstructive lesions. In this subgroup, 3D echo LV EDV and ESV correlated with MRI but were consistently higher ( Table 3 ). LV mass by 3D echo was comparable with MRI, with small mean differences ( Table 3 ). Although LV EF by 3D echo correlated with MRI, values were lower than by MRI ( Table 3 ).
Influence of Body Size on LV Volume Measurements
The mean difference between 3D echo and MRI EDV was not different between patients with a BSA median Ͻ0.37 m 2 and those with a BSA Ն0.37 m 2 (Ϫ0.55Ϯ5.8 versus 1.5Ϯ6.5 mL; Pϭ0.3). Likewise, the mean difference in LV ESV between 3D echo and MRI was not different between smaller and larger patients (Ϫ2.7Ϯ5.0 versus Ϫ2.7Ϯ4.3 mL; Pϭ0.98).
Intra-and Interobserver Reliability
Intra-and interobserver reliability results for 3D echo assessment of LV volumes and mass are shown in Table 4 .
Discussion
In this study of neonates and infants with complex CHD, high-quality full-volume 3D echo acquisitions to measure 3D mass and volumes could be obtained in the majority (87%) of patients. LV diastolic volumes and mass by matrix-array 3D echo compared well to those measurements by MRI. As compared to previous reports in adults [13] [14] [15] [16] and older children, 5, 17, 18 these findings are unique given the young age and small size of the patients and, hence, much smaller LVs. LV EDVs and mass also were small for BSA (ie, in patients with LV hypoplasia or critical aortic stenosis). Results of this Reported is the mean difference and 95% CIs between 3D echo and MRI. The P value is for the paired t test between 3D echo and MRI. nϭ35. study are consistent with those evaluating small ventricular volumes in in vitro balloon models, 19 in piglet hearts, 20 and with single-ventricular volumes by 3D echo and MRI in young pediatric patients with single-ventricle physiology. 10 Three-dimensional echo LV EDVs and mass compared well with MRI, even in patients with markedly dilated right ventricles or systemic right ventricular pressure, such as total anomalous pulmonary venous connections.
Previous studies in pediatric 10 and adult 15, 16 patients have reported that 3D echo volumes are smaller than by MRI. One pediatric study reported larger volumes by 3D echo when again compared to MRI. 5 The differences between echo and MRI are attributable to many factors, 10 including throughplane motion, which can affect disc measurement at the atrioventricular valve level. Equally important is differences in endocardial border depiction and tracing between the 2 modalities. This difference was certainly highlighted in this study in those pediatric patients with heavily trabeculated LVs. This finding was further accentuated during systole. The smaller hearts also seemed more susceptible to excessive translation motion, although this was not systematically evaluated in the present study. The larger LV EDV by 3D echo versus MRI in the subset of children with left-sided obstructive lesions may potentially bias decision-making toward a 2-ventricle repair. Although statistically significant, the mean difference between the modalities was small. EF by 3D echo was higher than by MRI (mean difference, 9.3%) with fair correlation. This small difference in measurements is consistent with other comparative echo versus MRI studies. 15 In this select pediatric population, with some patients having severe LV outflow obstructive disease, volumes and mass may be more important determinants to guide clinical decision-making than EF. EF will be significantly influenced by pre-and after-load conditions. Frame rates with the transducer used in this study are low, especially in relation to the fast heart rates of infants. Interframe data are interpolated, and this likely affects calculation of ESV as well as EDV. Recognition of end systole may be particularly difficult, especially at high heart rates. Endocardial border detection in some of these markedly hypertrophied and trabeculated LVs was equally challenging by both methods. These limitations likely account for some of the variance in both volume and EF measurements between 3D echo and MRI. Recent developments in 3D echo acquisition, including higher frequency probes and single-beat volume acquisition, may improve volume and mass measurements in this patient group. 21 Additionally, semiautomated algorithms have been developed that depend on landmark detection, mathematical modeling, and summation of polytetrahedrons. 22
Limitations
This study was performed in intubated and anesthetized patients in whom ventilation was suspended. Previous studies have shown that 3D echo can be successfully performed with adequate image quality in the majority of children without sedation or general anesthesia. 18, 23 Nonetheless, feasibility studies need to be done in pediatric patients who are awake or under conscious sedation. Clinical application will best be used in more conventional clinical settings.
Three-dimensional volume data sets were obtained from the subcostal position in this study. Other centers have reported LV volume measurements from the apical transducer position in the pediatric age group. In our small-sized patient population, the larger transducer was difficult to properly position in the apex because of rib constraints. Volume measurements should be similar regardless of view, and probe position should not influence measurements. Optimal probe position warrants further investigation.
Analysis of LV volumes and mass by summation of discs is time consuming but seems comparable to MRI. Future studies need to evaluate efficiency of this technology in the clinical setting. On the other hand, 3D echo image acquisition is fast and applicable in a multitude of clinical settings. 23
Conclusion
Three-dimensional echo can reliably measure small LV volumes and mass in neonates and infants with complex CHD. This methodology has the potential to be applied to a variety of outcome studies to best determine medical and surgical strategies, in particular pediatric patients with LV hypoplasia.
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